Detalhe da pesquisa
1.
Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer.
Pharm Res
; 35(2): 31, 2018 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29368289
2.
Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study.
Pharm Res
; 33(12): 2930-2942, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27528392
3.
Trastuzumab distribution in an in-vivo and in-vitro model of brain metastases of breast cancer.
Oncotarget
; 8(48): 83734-83744, 2017 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29137378
4.
Permeability across a novel microfluidic blood-tumor barrier model.
Fluids Barriers CNS
; 14(1): 3, 2017 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28114946
5.
Semi-automated rapid quantification of brain vessel density utilizing fluorescent microscopy.
J Neurosci Methods
; 270: 124-131, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27321229
6.
Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer.
Clin Exp Metastasis
; 33(4): 373-83, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26944053
7.
A novel preclinical method to quantitatively evaluate early-stage metastatic events at the murine blood-brain barrier.
Cancer Prev Res (Phila)
; 8(1): 68-76, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25348853